The post DuPont declares $0.20 dividend appeared first on Up2info.com.

Management View

• CEO Lori Koch reported that “we finished the year strong, delivering full year organic sales growth of 2%, operating EBITDA growth of 6% and 100 basis points of margin expansion.” Koch highlighted that

The post DuPont targets 3% organic sales growth and $2.25–$2.30 EPS for 2026 as portfolio transformation accelerates appeared first on Up2info.com.

DuPont (DD) posted fourth-quarter net sales of $1.7 billion, ahead of the consensus estimate of $1.69 billion. Revenue was essentially flat from a year earlier, reflecting a modest decline in volume that was offset by currency benefits and stable pricing.

Adjusted earnings came in at $0.46 a share, topping analyst estimates of $0.43 a share. The company reported a GAAP loss from continuing operations as separation-related costs weighed on results.

Net income narrowed to a loss of $108 million, or $0.27 a share, from a year-earlier loss of $291 million, or $0.70 a share.

Operating performance and margins improve

Operating earnings before interest, taxes, depreciation and amortization totaled $409 million in the quarter, up 4% from the prior year. Operating margins expanded to 24.2% from 23.4%, driven by favorable product mix and cost productivity initiatives.

Adjusted earnings growth reflected higher segment earnings and lower interest expense, partially offset by a higher effective tax rate, DuPont (DD) said.

“Our full year results capped a year of strong, disciplined execution,” Chief Executive Lori Koch said in the earnings release. “Our teams delivered against our commitments in a dynamic macro environment.”

Segment results show mixed demand

Healthcare and Water Technologies delivered organic sales growth of 3% in the quarter, led by strength in medical packaging, medical devices and industrial water markets. Segment ebitda rose 4%, while margins held steady at 31.1%.

Diversified Industrials posted a 4% organic sales decline as weakness in construction markets weighed on Building Technologies. Aerospace demand helped partially offset softness in printing and packaging. Segment ebitda increased 2%, with margins expanding 110 basis points.

Full-year results and cash flow

For full-year 2025, DuPont (DD) reported net sales of $6.8 billion, up 2% from the prior year, with organic growth of 2%. GAAP income from continuing operations totaled $98 million, or $0.21 a share, compared with a loss of $96 million, or $0.23 a share, in 2024.

Operating earnings before interest, taxes, depreciation and amortization rose 6% to $1.63 billion, while adjusted earnings increased 16% to $1.68 a share. Transaction-adjusted free cash flow climbed to $689 million.

2026 outlook

Looking ahead, DuPont (DD) initiated first-quarter 2026 guidance calling for net sales of about $1.67 billion and adjusted earnings of roughly $0.48 a share, matching the consensus estimate. For the full year, the company forecast net sales of $7.08 billion to $7.14 billion, ahead of the consensus estimate of $7.06 billion, and adjusted earnings of $2.25 to $2.30 a share, greater than the analyst forecast of $2.13 a share.

“Our 2026 guidance is in line with the medium-term targets communicated at our recent investor day,” Chief Financial Officer Antonella Franzen said.

The post DuPont tops fourth-quarter estimates, shares climb premarket appeared first on Up2info.com.

*Other Operating Data Consensus Source: Bloomberg

The post Earnings Snapshot: DuPont de Nemours beats Q4 profit estimates; sees FY26 outlook above forecast appeared first on Up2info.com.

The post DuPont beats Q4 estimates appeared first on Up2info.com.

The post DuPont Q4 2025 Earnings Preview appeared first on Up2info.com.

The proposed funding would consist of roughly $2.25 billion of leveraged loans denominated in dollars and euros, about $1 billion of privately placed junk bonds, and a $500 million revolving credit facility, the people said. Discussions with investors are under way, and the deal could be launched as early as this week.

Goldman had previously explored a different structure when it first tested market interest in September, centered on a $3 billion term loan, a $500 million revolver, and a $250 million delayed-draw facility.

Changes to the financing come after Arclin completed its acquisition of Willamette Valley Co., an adhesives manufacturer, and after its private equity sponsor, TJC LP, contributed additional equity toward the DuPont (DD) transaction. Proceeds from the debt package are also expected to be used to refinance existing term loans, though final terms remain subject to negotiation.

The shift toward bond financing reflects softer conditions in the US leveraged loan market, where recent selling pressure, particularly in software-related debt, has pushed a growing share of loans into distressed levels. A widely followed index of U.S. leveraged loans has recently fallen to a two-month low.

Banks have made similar adjustments elsewhere. Earlier this week, lenders reworked the financing for roughly $1.8 billion of debt tied to TreeHouse Foods Inc.’s acquisition by reducing the size of the loan tranche and relying more heavily on high-yield bonds.

Arclin agreed in August to buy DuPont’s (DD) aramids business for approximately $1.8 billion. The unit produces high-strength fibers used in applications such as body armor and fire-resistant apparel, and the transaction is expected to close in the first quarter of 2026.

Arclin most recently accessed the leveraged loan market in May 2024, when it raised $340 million in additional debt. DuPont (DD) has been divesting assets as part of a broader corporate reorganization announced last year.

The post Goldman is said to reshape financing package for Arclin’s DuPont aramids deal appeared first on Up2info.com.

The company gained about 3% in the preceding six sessions.

DD is up nearly 8.8% over the past one month. The stock closed 0.04% higher on Wednesday at $44.63.

Looking at Seeking Alpha’s Quant Rating, DD has a Strong Sell rating with a score of 1.20 out of 5. The company received a B in the prospect of valuation, while it got an F in the growth, momentum, and revisions.

Wall Street and Seeking Alpha analysts are, however, bullish on the stock.

Turning to the Wall Street community, 14 out of 17 analysts gave DD a Buy and above, three analysts have given the stock a Hold recommendation, and no one recommended Sell or lower.

Seeking Alpha analysts also see the stock as a Buy.

Seeking Alpha analyst AMO Research said DuPont de Nemours earns a Buy rating, driven by its strategic shift toward high-growth, high-margin water infrastructure and industrial safety markets.

“Despite trading at a premium to peers, DD’s superior margins, cost discipline, and $2B share repurchase program justify its valuation and support further upside,” AMO Research added.

Overall, the stock slipped over 41% in the past one year, compared to the 15% rise in the broader S&P 500 Index.

The post DuPont de Nemours snaps six straight sessions of gains appeared first on Up2info.com.

The Wilmington, DE-based chemical and materials company has added 3.58% over the course of the last six trading days.

A significant gain was logged on Friday, December 5, after DuPont said that its aramid fiber brand, Kevlar EXO, launched its use in hard armor applications, including helmets and ballistic plate inserts.

“The success of Kevlar® EXO™ in soft armor applications paved the way for its evolution into structural uses like hard armor,” said Gerrad Allison, marketing manager of defense at Kevlar® EXO.

DD closed the trading day 1.73% higher at $40.51.

DuPont de Nemours’ third-quarter results showed weaker year-over-year earnings and cash flow. Net income fell to $308 million, or $0.70 a share, from $453 million, or $1.06 a share, a year earlier.

Additionally, the chemical maker cut its quarterly dividend by more than half to $0.20 per share.

Nevertheless, the company raised its full-year earnings guidance. Also, it announced plans to return capital to shareholders, including a $2B share repurchase authorization and an imminent $500M accelerated buyback.

The stock is down ~45% year-to-date.

Seeking Alpha’s Quant rating system sees the stock as Strong Sell, considering factors such as growth, momentum, and earnings revisions.

However, SA authors grade the stock as Hold.

“I give DuPont a HOLD with a PT of $70 per share from a fair value of $83 per share for the longer term, legitimizing some of the company’s premium that we see here,” said Seeking Alpha analyst Wolf Report.

“I would be careful going higher,” added the analyst.

Meanwhile, the Wall Street community grades the stock as Strong Buy.

The post DuPont de Nemours extends gains for seventh straight trading day appeared first on Up2info.com.

The post DuPont cuts dividend by about half appeared first on Up2info.com.